About Creoptix
Creoptix is a company based in Wadenswil (Switzerland) founded in 2009 was acquired by Malvern Panalytical in January 2022.. Creoptix has raised $11.33 million across 2 funding rounds from investors including Zurcher Kantonalbank, Waters Corporation and Malvern Panalytical. Creoptix operates in a competitive market with competitors including DermaSensor, Cellix, ForteBio, InSilixa and Cortical Labs, among others.
- Headquarter Wadenswil, Switzerland
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.33 M (USD)
in 2 rounds
-
Latest Funding Round
$8.04 M (USD), Series C
Sep 30, 2019
-
Investors
Zurcher Kantonalbank
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Malvern Panalytical
(Jan 11, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Creoptix
Creoptix has successfully raised a total of $11.33M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $8.04 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $8.0M
-
First Round
First Round
(21 Nov 2013)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Series C - Creoptix | Valuation | unknown | |
| Nov, 2013 | Amount | Series A - Creoptix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Creoptix
Creoptix has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, Waters Corporation and Malvern Panalytical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
StartAngels Network is operated as a non-profit association connecting angel investors with Swiss startups.
|
Founded Year | Domain | Location | |
|
Provider of laboratory management system for researchers and clinicians
|
Founded Year | Domain | Location | |
|
Swisscanto is recognized as a leading fund manager in Switzerland.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Creoptix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Creoptix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Creoptix Comparisons
Competitors of Creoptix
Creoptix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermaSensor, Cellix, ForteBio, InSilixa and Cortical Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| domain | founded_year | HQ Location |
Microfluidics, biochips, and high-throughput gene-editing technologies are manufactured.
|
|
| domain | founded_year | HQ Location |
Real-time biomolecular interactions are analyzed using specialized instruments.
|
|
| domain | founded_year | HQ Location |
Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology.
|
|
| domain | founded_year | HQ Location |
Manufacturer of AI-powered biochips
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Creoptix
Frequently Asked Questions about Creoptix
When was Creoptix founded?
Creoptix was founded in 2009 and raised its 1st funding round 4 years after it was founded.
Where is Creoptix located?
Creoptix is headquartered in Wadenswil, Switzerland. It is registered at Wadenswil, Zurich, Switzerland.
Is Creoptix a funded company?
Creoptix is a funded company, having raised a total of $11.33M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.29M, raised on Nov 21, 2013.
What does Creoptix do?
Creoptix was founded in 2009 in Wadenswil, Switzerland, within the biotechnology sector. Optical instruments and consumables based on Grating-Coupled Interferometry technology are produced for label-free molecular interaction analysis. Sets for fragment-based screening and binding studies at low concentrations are offered, alongside carboxyl-coupling sensors suitable for various molecules. Software for integrated assay setup and data evaluation is also provided to support these operations.
Who are the top competitors of Creoptix?
Creoptix's top competitors include DermaSensor, Cortical Labs and Cellix.
Who are Creoptix's investors?
Creoptix has 6 investors. Key investors include Zurcher Kantonalbank, Waters Corporation, Malvern Panalytical, Swisscanto, and StartAngels Network.